Indivior Plc Share Price (NASDAQ: INDV)

$24.29

▲

0.41

(1.72%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Indivior Plc Stock chart to analyse performance

Indivior Plc stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$23.61
Today's High:$24.29
$24.29
2.8%
Downside
Day's Volatility :2.8%
Upside
0.0%
52 Weeks Low:$7.33
52 Weeks High:$25.00
$24.29
69.82%
Downside
52 Weeks Volatility :70.68%
Upside
2.84%

Indivior Plc Stock Returns

Period	Indivior Plc	Index (Russel 2000)
3 Months	94.86%	0.0%
6 Months	154.24%	0.0%
1 Year	99.51%	0.0%
3 Years	6.63%	-4.7%

Indivior Plc Key Stats

Check Indivior Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$23.88
Open	$23.83
Today's High	$24.29
Today's Low	$23.61
Market Capitalization	$3.0B
Today's Volume	$1.7M
52 Week High	$25.0
52 Week Low	$7.33
Revenue TTM	$1.2B
EBITDA	$336.0M
Earnings Per Share (EPS)	$0.81
PE Ratio	29.48
Profit Margin	4.52%
Quarterly Earnings Growth YOY	-0.15%
Return On Equity TTM	12.2%

Stock Returns calculator for Indivior Plc Stock including INR - Dollar returns

The Indivior Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Indivior Plc investment value today

Current value as on today

₹1,99,604

Returns

₹99,604

(+99.6%)

Returns from Indivior Plc Stock

₹94,320 (+94.32%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Indivior Plc Stock

550%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Indivior Plc Stock from India on INDmoney has increased by 550% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Indivior Plc Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Indivior Plc(by analysts ranked 0 to 5 stars)

Indivior Plc Share Price Target

What analysts predicted

Upside of 21.04%

Target:

$29.40

Current:

$24.29

Indivior Plc share price target is $29.40, a slight Upside of 21.04% compared to current price of $24.29 as per analysts' prediction.

Indivior Plc Stock Insights

Price Movement
In the last 1 month, INDV stock has moved up by 39.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 266.0M → 302.0M (in $), with an average increase of 11.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 59.0M → 18.0M (in $), with an average decrease of 41.0% per quarter

Indivior Plc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$815.2M	↓ 15.08%
Net Income	$139.1M	↓ 47.02%
Net Profit Margin	17.07%	↓ 10.29%

	FY20	Y/Y Change
Revenue	$689.7M	↓ 15.39%
Net Income	$-157.8M	↓ 213.38%
Net Profit Margin	-22.87%	↓ 39.94%

	FY21	Y/Y Change
Revenue	$777.5M	↑ 12.73%
Net Income	$205.0M	↓ 229.94%
Net Profit Margin	26.37%	↑ 49.24%

	FY22	Y/Y Change
Revenue	$884.6M	↑ 13.78%
Net Income	$-52.0M	↓ 125.38%
Net Profit Margin	-5.88%	↓ 32.25%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 23.55%
Net Income	$2.0M	↓ 103.84%
Net Profit Margin	0.18%	↑ 6.06%

	FY24	Y/Y Change
Revenue	$1.2B	↑ 8.69%
Net Income	$2.0M	↑ 0.0%
Net Profit Margin	0.17%	↓ 0.01%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$282.7M	↓ 5.96%
Net Income	$47.0M	↓ 12.96%
Net Profit Margin	16.62%	↓ 1.34%

	Q2 FY24	Q/Q Change
Revenue	$299.6M	↑ 5.97%
Net Income	$-107.2M	↓ 328.12%
Net Profit Margin	-35.79%	↓ 52.41%

	Q3 FY24	Q/Q Change
Revenue	$307.0M	↑ 2.47%
Net Income	$4.0M	↓ 103.73%
Net Profit Margin	1.3%	↑ 37.09%

	Q4 FY24	Q/Q Change
Revenue	$299.0M	↓ 2.61%
Net Income	$59.0M	↑ 1375.0%
Net Profit Margin	19.73%	↑ 18.43%

	Q1 FY25	Q/Q Change
Revenue	$266.0M	↓ 11.04%
Net Income	$47.0M	↓ 20.34%
Net Profit Margin	17.67%	↓ 2.06%

	Q2 FY25	Q/Q Change
Revenue	$302.0M	↑ 13.53%
Net Income	$18.0M	↓ 61.7%
Net Profit Margin	5.96%	↓ 11.71%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$650.0M	↓ 21.23%

	FY20	Y/Y Change
Profit	$573.5M	↓ 11.78%

	FY21	Y/Y Change
Profit	$639.9M	↑ 11.58%

	FY22	Y/Y Change
Profit	$715.8M	↑ 11.86%

	FY23	Y/Y Change
Profit	$907.0M	↑ 26.72%

	FY24	Y/Y Change
Profit	$957.0M	↑ 5.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$230.0M	↓ 6.23%

	Q2 FY24	Q/Q Change
Profit	$183.4M	↓ 20.26%

	Q3 FY24	Q/Q Change
Profit	$238.0M	↑ 29.79%

	Q4 FY24	Q/Q Change
Profit	$276.0M	↑ 15.97%

	Q1 FY25	Q/Q Change
Profit	$222.0M	↓ 19.57%

	Q2 FY25	Q/Q Change
Profit	$250.0M	↑ 12.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$156.8M	↓ 45.82%
Investing Cash Flow	$-2.1M	↓ 45.64%
Financing Cash Flow	$-13.5M	↓ 94.04%

	FY20	Y/Y Change
Operating Cash Flow	$-205.7M	↓ 231.21%
Investing Cash Flow	$-4.3M	↑ 105.31%
Financing Cash Flow	$-10.7M	↓ 21.04%

	FY21	Y/Y Change
Operating Cash Flow	$347.0M	↓ 268.65%
Investing Cash Flow	$-13.8M	↑ 222.73%
Financing Cash Flow	$-92.4M	↑ 766.76%

	FY22	Y/Y Change
Operating Cash Flow	$-3.9M	↓ 101.13%
Investing Cash Flow	$-218.9M	↑ 1491.11%
Financing Cash Flow	$-98.2M	↑ 6.27%

	FY23	Y/Y Change
Operating Cash Flow	$-315.0M	↑ 7920.73%
Investing Cash Flow	$-100.4M	↓ 54.16%
Financing Cash Flow	$-46.0M	↓ 53.15%

	FY24	Y/Y Change
Operating Cash Flow	$36.0M	↓ 111.43%
Investing Cash Flow	$69.0M	↓ 168.75%
Financing Cash Flow	$-102.0M	↑ 121.74%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-54.8M	↓ 80.97%
Investing Cash Flow	$24.9M	↑ 294.89%
Financing Cash Flow	$-37.8M	↑ 76.22%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$87.8M	↓ 260.4%
Investing Cash Flow	$2.1M	↓ 91.72%
Financing Cash Flow	$-36.1M	↓ 4.63%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$8.0M	↓ 90.89%
Investing Cash Flow	$32.0M	↑ 1452.25%
Financing Cash Flow	$-55.0M	↑ 52.44%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-5.0M	↓ 162.5%
Investing Cash Flow	$10.0M	↓ 68.75%
Financing Cash Flow	$27.0M	↓ 149.09%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$75.0M	↓ 1600.0%
Investing Cash Flow	$-5.0M	↓ 150.0%
Financing Cash Flow	$-17.0M	↓ 162.96%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$158.0M	↑ 110.67%
Investing Cash Flow	$-17.0M	↑ 240.0%
Financing Cash Flow	$-5.0M	↓ 70.59%

Indivior Plc Technicals Summary

Sell

Neutral

Buy

Indivior Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Indivior Plc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Indivior Plc	15.34%	154.24%	99.51%	6.63%	6.63%
Haleon Plc Spon Ads	1.5%	-7.33%	-3.49%	69.05%	32.32%
United Therapeutics Corporation	3.57%	-1.69%	-13.51%	34.83%	71.41%
Zoetis Inc.	6.13%	-8.28%	-14.8%	-1.88%	-3.48%
Neurocrine Biosciences Inc.	8.29%	21.94%	11.59%	32.16%	20.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Indivior Plc	29.48	29.48	NA	1.72	0.12	0.13	NA	-2.06
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Indivior Plc	Buy	$3.0B	6.63%	29.48	4.52%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-3.48%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	20.59%	41.3	13.88%

About Indivior Plc

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Organization	Indivior Plc
Employees	1000
CEO	Mr. Joseph J. Ciaffoni
Industry	Miscellaneous

Key Management of Indivior Plc

Name	Title
Mr. Joseph J. Ciaffoni	CEO & Director
Mr. Ryan Preblick	Chief Financial Officer
Mr. Vishal Kalia	Chief Strategy & Operating Officer
Dr. Christian Heidbreder	Chief Scientific Officer
Mr. Jason Thompson	Vice President of Investor Relations
Ms. Cynthia Cetani	Chief Integrity & Compliance Officer
Mr. Jeffrey W. Burris J.D.	Chief Legal Officer
Ms. Angela Colon-Mahoney M.S.	Chief Human Resources Officer
Mr. Hillel West	Chief Manufacturing & Supply Officer
Mr. Patrick A. Barry	Chief Commercial Officer

Important FAQs about investing in INDV Stock from India :

What is Indivior Plc share price today?

Indivior Plc share price today is $24.29 as on August 30, 2025 at 1:29 am IST at the close of the market. Indivior Plc share today touched a day high of $24.29 and a low of $23.61.

What is the 52 week high and 52 week low for Indivior Plc share?

Indivior Plc share touched a 52 week high of $25.00 and a 52 week low of $7.33. Indivior Plc stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $24.29, lower by 2.84% versus the 52 week high.

How to invest in Indivior Plc Stock (INDV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Indivior Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indivior Plc Shares that will get you 0.0618 shares as per Indivior Plc share price of $24.29 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Indivior Plc Stock (INDV) from India?

Indian investors can start investing in Indivior Plc (INDV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Indivior Plc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Indivior Plc share’s latest price of $24.29 as on August 30, 2025 at 1:29 am IST, you will get 0.4117 shares of Indivior Plc. Learn more about fractional shares .

What are the returns that Indivior Plc has given to Indian investors in the last 5 years?

Indivior Plc stock has given 6.63% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?